These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 7996008)
41. Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Cramer N; Klockgether J; Wrasman K; Schmidt M; Davenport CF; Tümmler B Environ Microbiol; 2011 Jul; 13(7):1690-704. PubMed ID: 21492363 [TBL] [Abstract][Full Text] [Related]
42. How and why to monitor Pseudomonas aeruginosa infections in the long term at a cystic fibrosis centre. Kalferstova L; Vilimovska Dedeckova K; Antuskova M; Melter O; Drevinek P J Hosp Infect; 2016 Jan; 92(1):54-60. PubMed ID: 26597636 [TBL] [Abstract][Full Text] [Related]
43. Complexity of Pseudomonas aeruginosa infection in cystic fibrosis: combined results from esterase electrophoresis and rDNA restriction fragment length polymorphism analysis. Denamur E; Picard B; Goullet P; Bingen E; Lambert N; Elion J Epidemiol Infect; 1991 Jun; 106(3):531-9. PubMed ID: 1675610 [TBL] [Abstract][Full Text] [Related]
45. Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment. Valenza G; Radike K; Schoen C; Horn S; Oesterlein A; Frosch M; Abele-Horn M; Hebestreit H Scand J Infect Dis; 2010 Dec; 42(11-12):885-9. PubMed ID: 20735333 [TBL] [Abstract][Full Text] [Related]
46. Comparison of arbitrarily primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. Kersulyte D; Struelens MJ; Deplano A; Berg DE J Clin Microbiol; 1995 Aug; 33(8):2216-9. PubMed ID: 7559985 [TBL] [Abstract][Full Text] [Related]
47. Gradient of genomic diversity in the Pseudomonas aeruginosa chromosome. Römling U; Greipel J; Tümmler B Mol Microbiol; 1995 Jul; 17(2):323-32. PubMed ID: 7494481 [TBL] [Abstract][Full Text] [Related]
48. Intraclonal genetic diversity amongst cystic fibrosis and keratitis isolates of Pseudomonas aeruginosa. Hall AJ; Fothergill JL; Kaye SB; Neal TJ; McNamara PS; Southern KW; Winstanley C J Med Microbiol; 2013 Feb; 62(Pt 2):208-216. PubMed ID: 23105019 [TBL] [Abstract][Full Text] [Related]
49. Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. Jain M; Ramirez D; Seshadri R; Cullina JF; Powers CA; Schulert GS; Bar-Meir M; Sullivan CL; McColley SA; Hauser AR J Clin Microbiol; 2004 Nov; 42(11):5229-37. PubMed ID: 15528719 [TBL] [Abstract][Full Text] [Related]
50. Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa. Aaron SD; Ramotar K; Ferris W; Vandemheen K; Saginur R; Tullis E; Haase D; Kottachchi D; St Denis M; Chan F Am J Respir Crit Care Med; 2004 Apr; 169(7):811-5. PubMed ID: 14670805 [TBL] [Abstract][Full Text] [Related]
51. Molecular epidemiology of Pseudomonas aeruginosa from cystic fibrosis in Sicily: genome macrorestriction analysis and rapid PCR-ribotyping. Agodi A; Sciacca A; Campanile F; Messina C; Barchitta M; Sciacca S; Stefani S New Microbiol; 2000 Jul; 23(3):319-27. PubMed ID: 10939047 [TBL] [Abstract][Full Text] [Related]
52. Pulsed-field gel electrophoresis analysis of a Pseudomonas aeruginosa pathovar. Römling U; Grothues D; Koopmann U; Jahnke B; Greipel J; Tümmler B Electrophoresis; 1992; 13(9-10):646-8. PubMed ID: 1459082 [TBL] [Abstract][Full Text] [Related]
53. Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients. Redero M; López-Causapé C; Aznar J; Oliver A; Blázquez J; Prieto AI J Antimicrob Chemother; 2018 Oct; 73(10):2770-2776. PubMed ID: 30052973 [TBL] [Abstract][Full Text] [Related]
54. Is genotyping of single isolates sufficient for population structure analysis of Pseudomonas aeruginosa in cystic fibrosis airways? Sommer LM; Marvig RL; Luján A; Koza A; Pressler T; Molin S; Johansen HK BMC Genomics; 2016 Aug; 17():589. PubMed ID: 27506816 [TBL] [Abstract][Full Text] [Related]
55. Impact of Pseudomonas aeruginosa genomic instability on the application of typing methods for chronic cystic fibrosis infections. Fothergill JL; White J; Foweraker JE; Walshaw MJ; Ledson MJ; Mahenthiralingam E; Winstanley C J Clin Microbiol; 2010 Jun; 48(6):2053-9. PubMed ID: 20410349 [TBL] [Abstract][Full Text] [Related]
56. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Mahenthiralingam E; Campbell ME; Speert DP Infect Immun; 1994 Feb; 62(2):596-605. PubMed ID: 8300217 [TBL] [Abstract][Full Text] [Related]
57. Comparison of ribotyping and genome fingerprinting of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Bennekov T; Colding H; Ojeniyi B; Bentzon MW; Høiby N J Clin Microbiol; 1996 Jan; 34(1):202-4. PubMed ID: 8748305 [TBL] [Abstract][Full Text] [Related]
59. Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Ernst RK; D'Argenio DA; Ichikawa JK; Bangera MG; Selgrade S; Burns JL; Hiatt P; McCoy K; Brittnacher M; Kas A; Spencer DH; Olson MV; Ramsey BW; Lory S; Miller SI Environ Microbiol; 2003 Dec; 5(12):1341-9. PubMed ID: 14641578 [TBL] [Abstract][Full Text] [Related]
60. Pyocin typing of Pseudomonas aeruginosa isolates from children with cystic fibrosis. Richardson CJ; Burke V; Bailey M; Fisher A Pathology; 1991 Jul; 23(3):229-32. PubMed ID: 1780188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]